Purpose: The aim of this study was to use intravoxel incoherent motion diffusion-weighted imaging to discriminate subtypes of renal neoplasms and to assess agreement between intravoxel incoherent motion (perfusion fraction, f p ) and dynamic contrast-enhanced magnetic resonance imaging (MRI) metrics of tumor vascularity. Subjects and Methods: In this Health Insurance Portability and Accountability ActYcompliant, institutional review boardYapproved prospective study, 26 patients were imaged at 1.5-T MRI using dynamic contrast-enhanced MRI with high temporal resolution and diffusion-weighted imaging using 8 b values (range, 0-800 s/mm 2 ). Perfusion fraction ( f p ), tissue diffusivity (D t ), and pseudodiffusivity (D p ) were calculated using biexponential fitting of the diffusion data. Apparent diffusion coefficient (ADC) was calculated with monoexponential fit using 3 b values of 0, 400, and 800 s/mm 2 . Dynamic contrast-enhanced data were processed with a semiquantitative method to generate model-free parameter cumulative initial area under the curve of gadolinium concentration at 60 seconds (CIAUC 60 ). Perfusion fraction, D t , D p , ADC, and CIAUC 60 were compared between different subtypes of renal lesions. Perfusion fraction was correlated with CIAUC 60 . Results: We examined 14 clear cell, 4 papillary, 5 chromophobe, and 3 cystic renal cell carcinomas (RCCs). Although f p had higher accuracy (area under the curve, 0.74) for a diagnosis of clear cell RCC compared with D t or ADC, the combination of f p and D t had the highest accuracy (area under the curve, 0.78). The combination of f p and D t diagnosed papillary RCC and cystic RCC with 100% accuracy, and clear cell RCC and chromophobe RCC, with 86.5% accuracy. There was significant strong correlation between f p and CIAUC 60 (r = 0.82; P G 0.001). Conclusion: Intravoxel incoherent motion parameters f p and D t can discriminate renal tumor subtypes. Perfusion fraction demonstrates good correlation with CIAUC 60 and can assess degree of tumor vascularity without the use of exogenous contrast agent. 
D
iffusion-weighted magnetic resonance imaging (DWI) derives image contrast from differences in the mobility (Brownian motion) of water in tissues. Restriction of the random motion of water by the local microenvironment can be assessed either qualitatively or quantitatively. The decay of signal intensity (SI) as a function of increasing diffusion-weighting factor (or b value) is commonly approximated by a monoexponential function to quantitatively assess restriction to the diffusion. The rate of decay is called the apparent diffusion coefficient (ADC) and can be mapped on a voxel-by-voxel basis as an ADC map. 1 Diffusion-weighted magnetic resonance imaging (MRI) is increasingly being used in the evaluation of renal lesions. Studies have shown lower ADC in malignant lesions compared to benign renal lesions. 2Y5 In addition, DWI has been used to examine renal cell carcinoma (RCC) subtypes. Clear cell RCCs (ccRCCs) account for approximately 70% of all RCCs and have relatively more aggressive behavior and worse prognosis compared with other subtypes. 6, 7 Furthermore, ccRCC and papillary RCC (pRCC) respond differently to available targeted therapies in advanced disease. 8, 9 These differences in biologic behavior and response to targeted therapies underscore the need for accurately differentiating RCC subtypes. Higher ADCs in clear cell renal cell carcinomas (RCC) have been reported compared with papillary and chromophobe subtypes, 10 albeit with variable degree of overlap.
Although most studies attribute the differences in ADC between RCC subtypes to differences in the tissue cellularity and/or architecture, 3, 4 it is important to realize that ADC measurements are influenced by tissue perfusion as well as the tissue cellularity. 11 The contribution of perfusion to the diffusion signal was elucidated by Le Bihan et al 12, 13 in their pioneering work on intravoxel incoherent motion (IVIM). The blood flow in a randomly oriented microvasculature, referred to as pseudodiffusion, contributes to diffusion signal decay predominantly at low b values (G200 s/mm 2 ). Perfusion effects can be resolved from the true tissue diffusion by acquiring DWI with a sufficiently wide range of b values, followed by biexponential curve fit. Such analysis can resolve pseudodiffusivity (D p ) and tissue diffusivity (D t ) separately, along with their respective volume fractions f p and (1j f p ).
14Y23
Intravoxel incoherent motion provides a unique glimpse at tissue perfusion, without the use of exogenous contrast. Chandarana et al 24 demonstrated higher f p and lower D t in enhancing renal masses compared with benign nonenhancing lesions. Because RCC subtypes differ in degree of vascularity and cellularity/tumor architecture, diffusion MRI parameters f p /D p and D t , reflecting 2 distinct processes that contribute to ADC, may together provide more sensitive and specific characterization of renal lesions.
Whereas f p was shown to be higher in gadolinium-enhancing lesions compared with nonenhancing lesions, 24 the relationship between f p and metrics of tumor perfusion from dynamic contrastenhanced (DCE) MRI is not fully understood. Oncologic studies and clinical trials that use DCE MRI have sometimes expressed tumor perfusion using a semiquantitative parameter cumulative initial area under the curve (CIAUC). This parameter is a measure of the gadolinium concentration (mmol s j1 mL j1 ) obtained from the area under the gadolinium-enhancement signal intensity (SI) curve over the first 60 seconds (CIAUC 60 ) after intravenous injection of contrast. 25, 26 The CIAUC 60 reflects the combined influence of blood volume, flow, and permeability but is likely dominated by blood volume. Given the promise of DWI in interrogating perfusion and vascular volume parameters with the advantage of not requiring exogenous contrast material, our study had 2 goals: 1) to assess agreement between f p and the DCE MRI metric of tumor perfusion CIAUC 60 . 2) to use IVIM parameters to discriminate subtypes of renal neoplasm.
MATERIALS AND METHODS

Patient Population
This Health Insurance Portability and Accountability ActY compliant, prospective, single-center study was performed after obtaining approval from our institutional review board and informed patient consent. Forty-one consecutive patients presenting for preoperative imaging of renal lesions from October 2009 to October 2011 were recruited for this study. Two patients were excluded because in one, no lesion was identified, and in the other, the lesion was subcentimeter in size. Another four patients were excluded because complete DCE and diffusion data were not available (because of patients' inability to tolerate examination [n = 2] and of technical errors [n = 2]), and nine patients were excluded because these patients did not undergo surgery at our institution and no tumor histology was available. Twenty-six patients were included in the final cohort (mean age, 57.7 years; range, 38Y75 years; 15 men with a mean age of 58.1 years and age range of 38Y72 years; 11 women with a mean age of 57.2 years and age range of 38Y75 years). For this study, histopathologic slides were re-reviewed by a board-certified pathologist with 19 years of experience in genitourinary histopathology who rendered the diagnosis of RCC subtype, using immunohistochemical stains when deemed necessary.
Magnetic Resonance Imaging
Magnetic resonance imaging at 1.5 T (Magnetom Avanto, maximum gradient strength 45 of mT/m; Siemens Medical Solutions, Erlangen, Germany) was performed in all patients using torso phasedarray coils. The routine renal protocol included the following breathhold sequences: coronal and axial T2-weighted half-Fourier Acquisition single-shot turbo spin-echo (HASTE), transverse T1-weighted gradient echo in-phase and opposed-phase, and transverse 3-dimensional (3D) T1-weighted fat-suppressed gradient echo (volume interpolated breath-hold examination) precontrast and postcontrast acquisition in the corticomedullary, nephrographic, and excretory phases of enhancement. The DWI and DCE acquisitions were performed before contrast administration for volume interpolated breath-hold examination acquisitions as detailed below.
Diffusion-Weighted Imaging
Transverse respiratory-triggered twice-refocused spin echo, bipolar gradient, single-shot echo planar DWI, with tridirectional trace-weighting diffusion gradients, was performed before contrast administration. 27 The following were used to acquire DWI: repetition time/echo time, 2700 to 4000/76 milliseconds; matrix, 192 Â 144 to 192; voxel size, 1.8 Â 1.8 Â 6 mm; 15 axial 6-mm slices with an interslice gap of 0.6 mm; bandwidth, 1628 Hz/pix; parallel imaging factor, 2; 8 b values (0, 50, 100, 150, 250, 400, 600, and 800 s/mm 2 ) 24 ; and 2 averages. Acquisition times ranged from 90 to 180 seconds, depending on the patient's respiratory pattern.
Dynamic Contrast-Enhanced MRI
Dynamic contrast-enhanced MRI was performed with a 3D volumetric T1-weighted gradient echo sequence using the view-sharing undersampling technique TWIST (time-resolved angiography with stochastic trajectories). 28, 29 Scanning started with a 5-second delay after initiation of intravenous contrast injection (but before the contrast reaching the abdominal structures) and continued for 4 minutes. Using an automated injector (Spectris; Medrad, Indianola, PA), 4 mL of gadopentetate dimeglumine (Magnevist; Berlex Laboratories, Wayne, NJ) was injected intravenously, followed by 20 mL saline flush, both at a rate of 2 mL/s. Image parameters were as follows: repetition time/echo time, 2.33/0.77 milliseconds; flip angle, 12 degrees; slice thickness, 2.5 mm; matrix, 256 Â 180; voxel size, 2.4 Â 1.7 Â 2.5 mm; bandwidth, 650 Hz/ pix; parallel imaging factor, 3; and 40 coronal slices acquired with each measure. Total acquisition time for the initial full k-space acquisition was 5 seconds. TWIST acquisition updates 20% of central k-space area (A) and 20% of outer k-space lines (B) at a temporal resolution of 1.2 seconds (28) for each repeat measurement. The initial 21 measures were acquired at 1.2 seconds temporal resolution in a long breath-hold (29 seconds), followed by 3 to 5 measures performed (acquisition time 8Y10 seconds) in a breath-hold every 30 seconds for 4 minutes.
MRI Analysis
Diffusion-Weighted Imaging
Diffusion-weighted imaging data in a DICOM format were transferred to a standard personal computer running an in-houseYdeveloped software package (FireVoxel, http://files.nyu.edu/hr18/public). 18, 23, 30 Two independent observers (with 5 years and 1 year of abdominal MRI experience) blinded to patient's clinical information and tumor histology segmented the entire lesion on the unweighted (b = 0) acquisition. This 3D region of interest (ROI) was propagated to the other b-value images to derive integrated SI values for all the b values.
A biexponential model was used to describe the behavior of the diffusion-weighted signal S(b) 14 :
This model assumes (1) a vascular compartment, occupying a fraction f p of the tissue volume and showing a pseudodiffusion An unconstrained fit of this biexponential model (Eq. 1.1) was performed to the integrated lesion SI decays to extract the 3 parameters f p , D p , and D t . Apparent diffusion coefficient was calculated with monoexponential fit of SI at b = 0, 400, and 800 s/mm 2 as in previous studies. 5, 34 SðbÞ ¼ S 0 expðÀb Â ADCÞ ð1:2Þ Parametric maps were also generated of each of these parameters from voxel-wise fits to Eq. 1.1 (for f p , D p , and D t , using all b values whose signals exceeded background noise) or Eq. 1.2 (for ADC, using b = 0, 400, and 800 s/mm 2 and the same noise threshold) of all voxels in the tumor ROI. These maps were qualitatively evaluated but were not considered in the statistical analysis.
Dynamic Contrast-Enhanced MRI
Two observers (with 4 and 2 years of abdominal MRI experience) independently analyzed DCE MRI data. Observers were blinded to patient's clinical information, diffusion data, and tumor histology. The images were transferred to a personal computer running FireVoxel software.
Targeted image coregistration was performed using normalized mutual information as the voxel similarity measure. 30 The entire tumor was segmented on a postcontrast acquisition that best demonstrated the lesion, and this ROI was copied to the entire time series. Integrated lesion SI versus time course of the renal tumor was recorded and converted to FIGURE 1. ADC (Â10 j3 mm 2 /s) parametric maps in representative cases of (A) chRCC, (B) ccRCC, (C) pRCC, and (D) cyRCC. Papillary RCC had the lowest ADC, followed by chRCC and ccRCC, with cyRCC having the highest ADC. At the group level, there was no significant difference between chRCC and ccRCC. gadolinium concentration using a phantom calibration method. 35 The area under the concentration curve over the first minute, CIAUC 60 , was computed using the trapezoid approximation.
Statistical Analysis
To assess interobserver agreement in DWI parameters, concordance correlation coefficient (RC) and intraclass correlation coefficient (ICC) were calculated for f p , D t, D p , ADC, and CIAUC 60 measures provided by both observers.
Renal lesions were compared in terms of each DWI (f p , D t, D p , ADC) and DCE (CIAUC 60 ) parameter using mixed-model analysis of variance. A separate mixed-model analysis was conducted for each measure using that measure as the dependent variable. Each mixed model included lesion type and reader as fixed classification factors. The covariance structure was modeled by assuming observations to be correlated only when acquired from the same patient and by allowing the error variance to differ across lesion types. The Tukey honestly significant difference test was used to correct for multiple comparisons when comparing lesion types. Logistic regression for correlated data was used to assess the ability of the imaging measures, alone and in combination, to discriminate ccRCC from other types of cancers. To identify a threshold value that maximized the diagnostic accuracy of detecting ccRCC, ROC analyses were used. Pearson rank correlations were used to characterize the association of f p with CIAUC 60 . Statistical significance was defined as P G 0.05. SAS 9.3 (SAS Institute, Cary, NC) was used for all computations.
RESULTS
Patient and Lesion Characteristics
A total of 26 lesions in 26 patients were included in the final cohort and were assessed with DWI and gadolinium-enhanced DCE MRI. All patients underwent surgery at our institution and, on histopathology, were found to have diagnosis of clear cell (ccRCC, n = 4), papillary (pRCC, n = 4), chromophobe (chRCC, n = 5), and cystic (cyRCC, n = 3) subtype of RCC (Table 1) .
Interobserver Agreement
The RC for the DWI parameters ranged from 0.95 to 0.99, and ICC ranged from 0.93 to 0.99. These results suggest excellent agreement between the 2 readers for all DWI measures. Similarly, both RC and ICC for CIAUC 60 were 0.98, suggesting excellent agreement between the 2 readers.
DWI Results: Individual Parameters
The ADC , D t , D p , and f p of all lesions categorized by subtype are shown in Tables 2 and 3 Similar trends were noted with D t calculated from biexponential fit (example fits in Fig. 2) , which was highest in cyRCC (2.50 T 0.10 Â 10 j3 mm 2 /s) and lowest in pRCC (0.90 T 0.10 Â 10 j3 mm 2 /s). The D t of the clear cell and chromophobe subtypes were between those of the pRCC and cyRCC (example parametric maps in Fig. 3 /s, ccRCC subtype could be diagnosed with a sensitivity of 85.7%, specificity of 62.5%, and accuracy of 75%. Lower specificity was due to overlap between ccRCC and that of chRCC and cyRCC.
Perfusion fraction f p obtained with biexponential fit (Fig. 2) had the highest accuracy for the diagnosis of ccRCC (AUC 0.74). Using an f p cutoff grater than 0.16, the clear cell subtype could be diagnosed with a sensitivity of 100%, specificity of 62.5%, and accuracy of 82.7%. Representative f p parametric maps are shown in Figure 4 .
The pseudodiffusion (D p ) rate was not significantly different between different subtypes and had the lowest accuracy for detection of ccRCC (AUC 0.53).
Multivariate Prediction Model
Multistep logistic regression identified f p and D t as the optimal 2 factors for the detection of ccRCC. The parameter f p was a significant predictor of the clear cell subtype after adjusting for D t (P = 0.0016). Using the 2-factor model containing f p and D t to discriminate clear cell from all other subtypes (combined) achieved an AUC of 0.78 with a sensitivity of 92.9% (26/28) and a specificity of 79.2% (19/24) .
Based on IVIM analysis, cyRCC and pRCC are hypovascular, with f p less than 0.16, unlike the other 2 subtypes. These 2 subtypes can be distinguished from each other based on D t . Cystic RCC could be diagnosed with 100% accuracy using cutoffs of f p less than 0.16 and D t greater than 1.5 Â 10 j3 mm 2 /s, and pRCC could be diagnosed with 100% accuracy with cutoffs of f p less than 0.16 and D t less than 1.5 Â 10 j3 mm 2 /s. All ccRCC and chRCC had f p greater than 0.16. Using f p greater than 0.16 and D t greater than 1.5 Â 10 j3 mm 2 /s, ccRCC could be diagnosed with accuracy of 86.5%, and similarly, using cutoffs of f p greater than 0.16 and D t less than 1.5 Â 10 j3 mm 2 /s, the chromophobe subtype could be diagnosed with 86.5% accuracy (Fig. 5) .
DCE Measurement
The more vascularized tumor types (ccRCC and chRCC) demonstrate higher CIAUC 60 compared with hypovascular pRCC and cyRCC (Tables 2 and 3 ). The CIAUC 60 was higher in the chromophobe compared with the clear cell subtype (12.2 vs 9.93 mmol s j1 mL j1 ), but this difference did not achieve statistical significance (P = 0.165). Using a CIAUC 60 cutoff of greater than 3.73 mmol s j1 mL j1 , ccRCC could be diagnosed with a sensitivity of 100%, specificity of 59.3%, and accuracy of 80.8%. FIGURE 4. f p parametric maps in representative cases of (A) chRCC, (B) ccRCC, (C) pRCC, and (D) cyRCC. At the group level, ccRCC and chRCC are hypervascular, with f p greater than 0.16, whereas cyRCC and pRCC were hypovascular, with f p less than 0.16. There was no significant difference in f p between ccRCC and chRCC at the group level.
There was substantial significant (P G 0.0001) positive correlation between f p and CIAUC 60 (r = 0.82) (Fig. 6 ).
DISCUSSION
Renal masses are increasingly discovered incidentally as use of medical imaging rises. 36, 37 The incidental discovery of a renal neoplasm can lead to a management dilemma because renal tumors have variable natural history, growth rate, histopathologic features, and clinical behavior depending on their subtype. 38, 39 Differences in prognosis and evolving treatment paradigms based on tumor aggressiveness emphasize the need for noninvasive tools to accurately differentiate between subtypes of RCC.
Studies have shown that DCE computed tomography and MRI can noninvasively differentiate ccRCC from pRCC on the basis of degree of enhancement. 40Y42 However, ccRCC and chRCC cannot always be differentiated because they show overlap in the enhancement pattern. Moreover, most patients with renal tumors are elderly individuals and may have renal dysfunction. For these patients, techniques such as DWI, which do not require exogenous contrast, are attractive alternatives. In this study, there was a high correlation between perfusion fraction f p and the DCE metric of tumor perfusion CIAUC 60 . Both f p and CIAUC 60 were significantly higher in the clear cell and chromophobe subtypes, compared with the hypovascular pRCC and cyRCC. Furthermore, neither f p nor CIAUC 60 showed significant difference between the clear cell and chromophobe subtypes. Thus, the information provided by f p was analogous to that obtained from the DCE parameter CIAUC 60 .
Low ADC values have been shown to differentiate pRCC from non-pRCC subtypes in patients undergoing DWI at 1.5 Twith b values of 0, 400, and 800 s/mm 2 . 5 In a study by Wang et al, 10 when DWI was performed at 3 T with b values of 0 and 500 s/mm 2 , ccRCCs showed a significantly higher mean ADC (1.849 Â 10 j3 mm 2 /s) than did the papillary (1.087 Â 10 j3 mm 2 /sec) and chromophobe (1.307 Â 10 j3 mm 2 /s) RCCs; however, the difference between pRCC and chRCC was not statistically significant. When ADC was calculated with , the difference in ADC value between the 3 subtypes was statistically significant. 10 The higher accuracy of ADC calculated with a b value of 800 s/mm 2 is understandable because it more closely proximates the true diffusion coefficient (D t ) calculated in our study, which also significantly differentiated the RCC subtypes. However, in the study by Wang et al, 10 contrast-enhanced imaging was used to facilitate ROI placement to exclude area of necrosis or cystic degeneration, and only a small portion of the tumor was sampled with an average ROI of 100 mm 2 . We, on the other hand, segmented the entire lesion on the b0 image, which circumvents the limitations of sampling errors inherent to placing small ROIs or sampling bias from relying on contrast enhancement for ROI placement.
Selected recent studies have also recognized the limitations of the single ADC parameter in describing renal masses. Doganay et al 43 and Erbay et al 44 collected diffusion data at multiple b values in patients with varied renal mass pathologies and demonstrated that differentiation improves using ADCs at higher b values but did not explicitly quantify IVIM parameters. Rheinheimer et al 45 used the IVIM technique in a series of renal masses and found that the perfusion fraction provided significant added value, particularly in the differentiation of clear cell from nonYclear cell neoplasm. However, in this study, authors did not evaluate the combination of f p and D t in discriminating RCC subtypes.
Substantial evidence is thus accruing in the literature that the optimum application of DWI for renal tumor assessment should resolve and quantify different contributions to ADC. The present study using the IVIM method was carried out from this perspective. Intravoxel incoherent motion can simultaneously assess tumor vascularity and cellularity/architecture. The ability to explore both these metrics in our study showed higher accuracy when compared with ADC in discriminating RCC subtypes.
Assessment of treatment response of metastatic RCC to antiangiogenic drug therapy with DCE MRI has been performed in preclinical studies and in clinical trials. 46, 47 This powerful tool is not yet routinely used in clinical practice, in part because it is technically difficult to perform and there is some controversy regarding appropriate pharmacokinetic models for assessment of RCC. 48 We have shown that the IVIM parameter of tumor vascularity f p is significantly correlated with the DCE metric CIAUC 60 . This finding is most likely a result of the dominant contribution of blood volume to the latter metric. Given the vascular sensitivity of f p , an investigation of its ability to assess treatment response to antiangiogenic drug therapy without the need for exogenous contrast is highly warranted. Intravoxel incoherent motion DWI is relatively easy to perform and can be added to any existing renal MRI protocol. Imaging vendors are pursuing online processing of IVIM data at the scanner to generate f p and D t parametric maps, further facilitating the wider adoption of IVIM in clinical practice. Parametric maps were qualitatively evaluated in this study but were not used for quantitative evaluation. Heterogeneity at the edges of the f p and D t parametric maps (Figs. 3 and 4 ) may be related to partial volume averaging.
Several studies have shown that noncontrast MRI methods such as arterial spin labeling (ASL) can also be used to assess treatment response to antiangiogenic therapy in metastatic renal cancer.
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Quantitation of perfusion with ASL is slightly more technically challenging compared with calculation of perfusion fraction f p with IVIM DWI. However, future studies using a joint ASL-DWI encoding scheme, as previously reported in cerebral perfusion studies, 52, 53 may further illuminate the RCC microenvironment by probing both intravascular and extravasational dynamics.
The limitations of our study include a relatively small number of subjects. Although in this feasibility study we were able to use IVIM parameters in discriminating RCC subtypes with some degree of overlap between chRCC and ccRCC, larger studies and more detailed lesion analysis are required to assess diagnostic performance in accurately discriminating RCC subtypes. We compared f p with a model-free semiquantitative parameter CIAUC 60 instead of using a pharmacokinetic model such as Toft's model because its parameters' interpretation may vary with RCC subtype. 48 For example, the commonly used transfer constant K trans may reflect vessel permeability in hypervascular tumors such as clear cell and chromophobe subtypes but may reflect blood flow in hypovascular tumors such as pRCC and cyRCC. Finally, whereas the IVIM sensitivities in renal lesions are expected to be general, the specific mean values and discrimination thresholds in the current study (D t = 1.5 Â 10 j3 mm 2 /s, f p = 0.16) may be unique to our particular protocol. Estimations of IVIM parameters are known to depend somewhat upon b-value selection, 54Y56 relaxation weighting, 57 and analysis algorithm. 58, 59 Thus, a consistent protocol in any comparative study of lesion subtypes is vital to achieving meaningful discriminatory power with IVIM biomarkers.
In conclusion, in this pilot study, we were able to demonstrate the feasibility of performing IVIM DWI and show the use of f p and D t in the assessment of renal tumor subtype. A combination of IVIM parameters f p and D t can discriminate renal tumor subtypes with accuracy higher than that of monoexponential ADC. The parameter f p is correlated with the DCE metric of tumor vascularity CIAUC 60 and can assess the degree of tumor vascularity without the use of exogenous contrast agent. This study also suggests the potential of IVIM for simultaneous assessment of multiple tumor microenvironment properties. 
